{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:04:26Z","timestamp":1792807466949,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001348","name":"Agency for Science Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-Sen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ijantimicag.2022.106582","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T21:05:36Z","timestamp":1648847136000},"page":"106582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Repurposing Non-Antibiotic Drugs Auranofin and Pentamidine in Combination to Combat Multidrug-Resistant Gram-Negative Bacteria"],"prefix":"10.1016","volume":"59","author":[{"given":"Yingxiao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongshao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2022.106582_bib0001","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature17042","article-title":"Antibacterial drug discovery in the resistance era","volume":"529","author":"Brown","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0002","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/QCO.0b013e328332e672","article-title":"Colistin in the 21st century","volume":"22","author":"Nation","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106480","article-title":"The surveillance of colistin resistance and mobilized colistin resistance genes in multidrug-resistant Enterobacteriaceae isolated in Japan","volume":"59","author":"Kawamoto","year":"2022","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0004","series-title":"Antibacterial agents in clinical development \u2013 an analysis of the antibacterial clinical development pipeline, including Mycobacterium tuberculosis","year":"2017"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1473-3099(11)70316-4","article-title":"The crisis of no new antibiotics-what is the way forward?","volume":"12","author":"Piddock","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0006","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2174\/1381612823666170209154745","article-title":"In vitro screening of an FDA-approved library against ESKAPE pathogens","volume":"23","author":"Younis","year":"2017","journal-title":"Curr Pharm Design"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41598-020-62696-3","article-title":"Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae","volume":"10","author":"Elkashif","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0008","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/srep22571","article-title":"Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens","volume":"6","author":"Thangamani","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0009","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1504022112","article-title":"Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis","volume":"112","author":"Harbut","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0010","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/jac\/dkv163","article-title":"Auranofin efficacy against MDR Streptococcus pneumoniae and Staphylococcus aureus infections","volume":"70","author":"Aguinagalde","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0011","first-page":"12","article-title":"A macromolecule reversing antibiotic resistance phenotype and repurposing drugs as potent antibiotics","volume":"7","author":"Ding","year":"2020","journal-title":"Adv Sci"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0012","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2165\/00003495-198733030-00002","article-title":"Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia","volume":"33","author":"Goa","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/nmicrobiol.2017.28","article-title":"Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance","volume":"2","author":"Stokes","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0014","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/acsinfecdis.9b00221","article-title":"Lysine-based small molecule sensitizes rifampicin and tetracycline against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"6","author":"Konai","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0015","first-page":"3336","article-title":"Selection of mutants with resistance or diminished susceptibility to ceftazidime\/avibactam from ESBL-and AmpC-producing Enterobacteriaceae","volume":"73","author":"Livermore","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0016","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1021\/acsinfecdis.9b00486","article-title":"Overcoming multidrug resistance and biofilms of pseudomonas aeruginosa with a single dual-function potentiator of beta-lactams","volume":"6","author":"Lam","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0017","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/15027732.1986.12461436","article-title":"Pharmacology of auranofin: overview and update","volume":"63","author":"Gottlieb","year":"1986","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0018","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1128\/AAC.01947-16","article-title":"Phase I clinical trial results of auranofin, a novel antiparasitic agent","volume":"61","author":"Capparelli","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0019","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/infdis\/156.6.885","article-title":"Pentamidine pharmacokinetics in patients with AIDS with impaired renal function","volume":"156","author":"Conte","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2022.106582_bib0020","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.44.7.1771-1777.2000","article-title":"Mutation frequencies and antibiotic resistance","volume":"44","author":"Martinez","year":"2000","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857922000826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857922000826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:43:58Z","timestamp":1760377438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857922000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0924857922000826"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106582","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing Non-Antibiotic Drugs Auranofin and Pentamidine in Combination to Combat Multidrug-Resistant Gram-Negative Bacteria","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2022.106582","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106582"}}